| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 08/24/2000 | WO2000048990A1 Phthalamide-lanthanide complexes for use as luminescent markers |
| 08/24/2000 | WO2000048638A2 Multi-mutant diphtheria toxin vaccines |
| 08/24/2000 | WO2000048631A2 Adjuvant and cell maturation agent |
| 08/24/2000 | WO2000048629A1 USE OF AN OmpA ENTEROBACTERIUM PROTEIN ASSOCIATED WITH THE ELAGIGILTV PEPTIDE FOR TREATING MELANOMAS |
| 08/24/2000 | WO2000048628A1 Use of an enterobacterium protein ompa associated with an antigen for generating an antiviral, antiparasitic or antitumoral cytotoxic response |
| 08/24/2000 | WO2000048627A1 Inhibitors of separin, method for identifying them and uses |
| 08/24/2000 | WO2000048625A2 Inhibitors for use in hemostasis and immune function |
| 08/24/2000 | WO2000048595A1 A novel anti-angiogenic agent comprising at least one kringle region and an upstream pre-activation domain of plasminogen |
| 08/24/2000 | WO2000048558A1 Modified calycins |
| 08/24/2000 | WO2000034652A8 Methods of identifying point mutations in a genome |
| 08/24/2000 | WO2000032039A8 PURIFIED AND ISOLATED piwi FAMILY GENES AND GENE PRODUCTS AND METHODS EMPLOYING SAME |
| 08/24/2000 | WO2000031126A3 Suppression of xenotransplant rejection |
| 08/24/2000 | WO2000029550A3 Low oxygen culturing of central nervous system progenitor cells |
| 08/24/2000 | WO2000025138A3 Methods of diagnosing or prognosing alzheimer's disease |
| 08/24/2000 | WO2000024868A3 Rapid recovery of shoots through thin stem slices after preconditioning of micropropagated fruit tree shoots |
| 08/24/2000 | WO2000024775A9 Gene cluster involved in nogalamycin biosynthesis, and its use in production of hybrid antibiotics |
| 08/24/2000 | WO2000023469A3 Fragments of insulin-like growth factor binding protein and insulin-like growth factor, and uses thereof |
| 08/24/2000 | WO2000023100A9 Genes and proteins predictive and therapeutic for renal disease and associated disorders |
| 08/24/2000 | WO2000022167A9 Method for determining transcription factor activity and its technical uses |
| 08/24/2000 | WO2000022134A3 Test kit for diagnosis of borrelia infection and novel borrelia antigens for the development of vaccines |
| 08/24/2000 | WO2000022113A9 ENZYMATIC SYNTHESIS OF ssDNA |
| 08/24/2000 | WO2000022112A9 Stabilized bioactive peptides and methods of identification, synthesis and use |
| 08/24/2000 | WO2000021987A9 A method of identifying modulators of cell surface membrane receptors useful in the treatment of disease |
| 08/24/2000 | WO2000020605A9 Sulfotransferase sequence variants |
| 08/24/2000 | WO2000020566A9 Cytochrome p450 monooxygenase and nadph cytochrome p450 oxidoreductase genes and proteins related to the omega hydroxylase complex of candida tropicalis and methods relating thereto |
| 08/24/2000 | WO2000020434A9 Cadherin-like asymmetry protein-1, and methods for its use |
| 08/24/2000 | WO2000020025A9 Akt compositions for enhancing survival of cells |
| 08/24/2000 | WO2000020018A9 Kappa-a conopeptides and uses therefor |
| 08/24/2000 | WO2000018963A8 Methods for breeding for and screening of soybean plants with enhanced yields, and soybean plants with enhanced yields |
| 08/24/2000 | WO2000018962A9 Methods and compositions for amplifying detectable signals in specific binding assays |
| 08/24/2000 | WO2000018922A8 Human carbohydrate-associated proteins |
| 08/24/2000 | WO2000018917A9 α-SYNUCLEIN SUPER-MUTANTS ACCELERATE α-SYNUCLEIN AGGREGATION |
| 08/24/2000 | WO2000017365A3 Binary viral expression system in plants |
| 08/24/2000 | WO2000015797A3 Compositions and methods for the treatment of immune related diseases |
| 08/24/2000 | WO2000015796A3 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 08/24/2000 | WO2000015783A9 ANTISENSE OLIGONUCLEOTIDE COMPOSITIONS TARGETED TO β1-ADRENOCEPTOR-SPECIFIC mRNA AND METHODS OF USE |
| 08/24/2000 | WO2000015772A9 Recombinant protein production in urine |
| 08/24/2000 | WO2000015246A9 Regulation of lung tissue by hedgehog-like polypeptides, and formulations and uses related thereto |
| 08/24/2000 | WO2000014281A3 Assays using crosslinkable immobilized nucleic acids |
| 08/24/2000 | WO2000013654A3 A carotenoid composition containing phytoene and phytofluene |
| 08/24/2000 | WO2000013017A9 Method and device for producing and/or analyzing biochemical reaction supporting materials |
| 08/24/2000 | WO2000012685A3 Genes associated with neurotransmitter processing |
| 08/24/2000 | WO2000005390A3 Controlling starch synthesis |
| 08/24/2000 | WO2000005382A3 A nucleic acid encoding a geranyl-geranyl pyrophosphate synthetase (ggpps) and polymorphic markers associated with said nucleic acid |
| 08/24/2000 | WO1999067379A3 Structured antisense nucleic acid molecules |
| 08/24/2000 | WO1999057280A3 Neisseria meningitidis antigens and compositions |
| 08/24/2000 | WO1999046371A3 Induction of apoptotic or cytotoxic gene expression by adenoviral mediated gene codelivery |
| 08/24/2000 | WO1999042828A3 Treating cancer |
| 08/24/2000 | WO1998024898A3 Therapeutic composition comprising the kal protein and use of the kal protein |
| 08/24/2000 | DE4193302C2 Verwendung rekombinanter Antikörper spezifisch für TNF-alpha Using recombinant antibody specific for TNF-alpha |
| 08/24/2000 | DE19907598A1 New DNA encoding plant FK506-binding protein analog useful for producing transgenic plants with altered architecture and for studying immunosuppressants |
| 08/24/2000 | DE19907209A1 Nucleic acid, useful for producing transgenic plants with altered nucleobase transport, encodes a nucleobase transporter protein of Arabidopsis thaliana |
| 08/24/2000 | DE19907115A1 New Gluconobacter oxydans strain with high tolerance to D-sorbitol, useful for converting D-sorbitol to L-sorbose in the production of ascorbic acid |
| 08/24/2000 | DE19907023A1 Isolation of nucleic acids, useful for e.g. genetic diagnosis by amplification, by adsorption onto polymeric beads at neutral or acidic pH then release at basic pH |
| 08/24/2000 | DE19860834C1 Methode zur zellulären High-Throughput-Detektion von nukleären Rezeptor-Liganden-Interaktionen Method for cellular high-throughput detection of nuclear receptor-ligand interactions |
| 08/24/2000 | DE10006491A1 Selective enrichment or separation of biological material e.g. organisms, organs tissues, organelles, and membranes, in liquid media, comprises using stationary and mobile phases |
| 08/24/2000 | CA2372059A1 Use of an ompa enterobacterium protein associated with the elagigiltv peptide for treating melanomas |
| 08/24/2000 | CA2371880A1 Method and sample support system for separating and processing substances in situ |
| 08/24/2000 | CA2371825A1 Computer-implemented nucleic acid isolation method and apparatus |
| 08/24/2000 | CA2371821A1 Novel g protein-coupled receptor protein and dna thereof |
| 08/24/2000 | CA2368461A1 Glucose dehydrogenase fusion proteins and their utilization in expression systems |
| 08/24/2000 | CA2364267A1 Compositions and methods for non-targeted activation of endogenous genes |
| 08/24/2000 | CA2363063A1 Helper dependent adenovirus vectors based on site-specific recombinases |
| 08/24/2000 | CA2363061A1 Production of helper dependent adenovirus vectors based on use of endonucleases |
| 08/24/2000 | CA2362987A1 Receptor assay |
| 08/24/2000 | CA2362979A1 Method for isolating nucleic acids |
| 08/24/2000 | CA2362970A1 Hormone-hormone receptor complexes and nucleic acid constructs and their use in gene therapy |
| 08/24/2000 | CA2362943A1 Pyk2 binding proteins |
| 08/24/2000 | CA2362926A1 Method for producing l-sorbose |
| 08/24/2000 | CA2362807A1 Multi-mutant diphtheria toxin vaccines |
| 08/24/2000 | CA2362650A1 Lysophosphatidic acid acetyltransferases |
| 08/24/2000 | CA2362538A1 Secreted proteins and polynucleotides encoding them |
| 08/24/2000 | CA2362330A1 A novel anti-angiogenic agent comprising at least one kringle region and an upstream pre-activation domain of plasminogen |
| 08/24/2000 | CA2362300A1 Human lipid-associated proteins |
| 08/24/2000 | CA2362284A1 Modified calycins |
| 08/24/2000 | CA2362192A1 Use of an enterobacterium protein ompa associated with an antigen for generating an antiviral, antiparasitic or antitumoral cytotoxic response |
| 08/24/2000 | CA2361273A1 Inhibitors for use in hemostasis and immune function |
| 08/24/2000 | CA2359613A1 Methods for determining the presence of nucleic acid target sequences and applications thereof |
| 08/24/2000 | CA2359610A1 Malaria vaccine |
| 08/24/2000 | CA2357011A1 Multiplex method for nucleic acid detection |
| 08/24/2000 | CA2356927A1 Detection of nucleic acid hybrids |
| 08/24/2000 | CA2325385A1 Genes encoding proteins having activity of transferring sugar onto aurone |
| 08/24/2000 | CA2296782A1 Downstream genes of tumor suppressor wt1 |
| 08/24/2000 | CA2262056A1 Composition, methods and reagents for the synthesis of a soluble form of human pex |
| 08/23/2000 | EP1029925A1 Method for producing xylitol |
| 08/23/2000 | EP1029924A1 Nucleic acids having promoter activity and transgenic plants containing the same |
| 08/23/2000 | EP1029923A1 Method for conveying BNYVV resistance to sugar beet plants |
| 08/23/2000 | EP1029922A2 DNA fragments having basidiomycete-derived promoter activity and their use |
| 08/23/2000 | EP1029921A1 Serpin resistant chymotrpsin superfamily proteases, particularly PAI-1 resistant t-PA, complementary inhibitor mutants; compositions; genes; expressions |
| 08/23/2000 | EP1029920A1 Alkaline protease |
| 08/23/2000 | EP1029919A2 Process for the fermentative production of L-amino acids using coryneform bacteria |
| 08/23/2000 | EP1029918A1 Killer t cell receptor recognizing human immunodeficiency virus |
| 08/23/2000 | EP1029917A1 The LTR region of MSRV-1 and the proteins it encodes, and probes and methods for detecting MSRV-1 retrovirus |
| 08/23/2000 | EP1029916A1 Human lysophosphatidic acid receptor and use thereof |
| 08/23/2000 | EP1029915A2 Expression of G protein coupled receptors in yeast |
| 08/23/2000 | EP1029914A2 Growth hormone-regulated growth marker gene |
| 08/23/2000 | EP1029870A2 Hybrid Immunoglobulins |
| 08/23/2000 | EP1029547A1 Pharmaceutically active compounds and method for identifying same |
| 08/23/2000 | EP1029084A2 Specific and sensitive method for detecting nucleic acids |
| 08/23/2000 | EP1029083A2 Specific and sensitive nucleic acid detection method |